{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T20:06:36Z","timestamp":1771185996059,"version":"3.50.1"},"reference-count":36,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Prescription digital therapeutics (PDTx) represent an emerging frontier in healthcare, leveraging software-based solutions to treat or manage specific medical conditions. However, despite rising interest and encouraging evidence of clinical benefits, the policy landscape remains fragmented. Jurisdictions vary widely in their regulatory approaches, reimbursement pathways and processes for clinical integration, thus creating uncertainties for developers, payers and healthcare providers. This protocol outlines an eDelphi study to develop and validate a comprehensive policy maturity framework guiding systematic assessment of national or regional readiness for PDTx adoption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct an e-Delphi study with up to three rounds to refine and validate a PDTx policy maturity framework. Experts will be recruited purposively from six stakeholder groups (regulators, healthcare providers, payers\/health economists, developers, researchers and patient advocates), prioritising Europe while seeking variation across health system types and levels of economic development; a small number of non-European experts may be invited to broaden perspectives. An optional pilot round will gather initial feedback on the prototype framework, followed by iterative rounds to assess and revise domains, scoring criteria and maturity thresholds. A 5-point Likert scale (from \u2018strongly disagree\u2019 to \u2018strongly agree\u2019) will collect quantitative data, while open-text prompts will capture qualitative insights. Consensus will be defined as \u226570% agreement and\/or an IQR \u22641 for critical items. Quantitative summaries and thematic analysis will guide iterative revisions of the model. This Delphi protocol aims to produce a consensus-driven framework that captures the essential elements of PDTx policy development and implementation. If validated, the framework can serve as a reference for policymakers, industry leaders, healthcare providers and researchers seeking to benchmark or advance the adoption of PDTx within health systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval for this study was obtained from the Ethics Committee of the Faculty of Medicine of the University of Porto (reference: 320\/CEFMUP\/2025). Panellists will provide electronic informed consent, and data will be kept confidential. The finalised framework will be disseminated via peer-reviewed publications, conference presentations and policy briefs targeting stakeholders involved in digital health governance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-104466","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T19:30:17Z","timestamp":1771183817000},"page":"e104466","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-4952","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Rocha-Gomes","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Community Medicine, Health Information and Decision, University of Porto, Porto, Portugal"}]},{"given":"Bernardo","family":"Sousa-Pinto","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Community Medicine, Health Information and Decision, University of Porto, Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-7211","authenticated-orcid":false,"given":"Ana Luisa","family":"Neves","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Community Medicine, Health Information and Decision, University of Porto, Porto, Portugal"},{"name":"Department of Primary Care and Public Health, Imperial College London, London, UK"}]}],"member":"239","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"2026021511300996000_16.2.e104466.1","doi-asserted-by":"crossref","unstructured":"Compagnone AM , Cole RI . Digital therapeutics, in digital health. Elsevier, 2025:187\u2013203.","DOI":"10.1016\/B978-0-443-23901-4.00013-1"},{"key":"2026021511300996000_16.2.e104466.2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41746-023-00777-z","article-title":"Digital therapeutics from bench to bedside","volume":"6","author":"Wang","year":"2023","journal-title":"npj Digit Med"},{"key":"2026021511300996000_16.2.e104466.3","doi-asserted-by":"crossref","unstructured":"Cho C-H , Lee H-J , Kim Y-K . The new emerging treatment choice for major depressive disorders: digital therapeutics. In: Recent advances and challenges in the treatment of major depressive disorder. 2024: 307\u201331.","DOI":"10.1007\/978-981-97-4402-2_16"},{"key":"2026021511300996000_16.2.e104466.4","doi-asserted-by":"crossref","unstructured":"Andreoni G . The future digital pharmacological prescriptions between therapy adherence and integrated healthcare personal plans. In: In-home medication: integrating multidisciplinary perspectives in design-driven pharma practices. Springer, 2024: 177\u201388.","DOI":"10.1007\/978-3-031-53294-8_9"},{"key":"2026021511300996000_16.2.e104466.5","doi-asserted-by":"crossref","DOI":"10.2196\/49003","article-title":"Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping","volume":"11","author":"van Kessel","year":"2023","journal-title":"JMIR Mhealth Uhealth"},{"key":"2026021511300996000_16.2.e104466.6","doi-asserted-by":"crossref","DOI":"10.1080\/21614083.2021.2014047","article-title":"DiGA - A Chance for the German Healthcare System","volume":"11","author":"Sauermann","year":"2022","journal-title":"J Eur CME"},{"key":"2026021511300996000_16.2.e104466.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19073747","article-title":"Mobile Health (m-Health) in Retrospect: The Known Unknowns","volume":"19","author":"Istepanian","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026021511300996000_16.2.e104466.8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12265-022-10232-1","article-title":"Navigating the Regulatory Pathway for Medical Devices-a Conversation with the FDA, Clinicians, Researchers, and Industry Experts","volume":"15","author":"Lottes","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"2026021511300996000_16.2.e104466.9","unstructured":"Mechael P , Batavia H , Kaonga N , et al . Barriers and gaps affecting mHealth in low and middle income countries [Policy white paper]. 2010."},{"key":"2026021511300996000_16.2.e104466.10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.51594\/imsrj.v4i5.1158","article-title":"A review of the challenges and opportunities in implementing health informatics in rural healthcare settings","volume":"4","author":"Abdul","year":"2024","journal-title":"Imsrj"},{"key":"2026021511300996000_16.2.e104466.11","doi-asserted-by":"crossref","DOI":"10.2196\/48000","article-title":"Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review","volume":"25","author":"van Kessel","year":"2023","journal-title":"J Med Internet Res"},{"key":"2026021511300996000_16.2.e104466.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2011.02.011"},{"key":"2026021511300996000_16.2.e104466.13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41746-023-00899-4","article-title":"Barriers and facilitators to utilizing digital health technologies by healthcare professionals","volume":"6","author":"Borges do Nascimento","year":"2023","journal-title":"npj Digit Med"},{"key":"2026021511300996000_16.2.e104466.14","doi-asserted-by":"crossref","DOI":"10.2196\/14994","article-title":"Identifying and Overcoming Policy-Level Barriers to the Implementation of Digital Health Innovation: Qualitative Study","volume":"21","author":"Desveaux","year":"2019","journal-title":"J Med Internet Res"},{"key":"2026021511300996000_16.2.e104466.15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/1357633X17730444","article-title":"Virtual care policy recommendations for patient-centred primary care: findings of a consensus policy dialogue using a nominal group technique","volume":"24","author":"Shaw","year":"2018","journal-title":"J Telemed Telecare"},{"key":"2026021511300996000_16.2.e104466.16","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.9.3.458"},{"key":"2026021511300996000_16.2.e104466.17","doi-asserted-by":"publisher","DOI":"10.1108\/09654280310459112"},{"key":"2026021511300996000_16.2.e104466.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-024-07937-w","article-title":"Digital health interventions for all? Examining inclusivity across all stages of the digital health intervention research process","volume":"25","author":"Krukowski","year":"2024","journal-title":"Trials"},{"key":"2026021511300996000_16.2.e104466.19","doi-asserted-by":"publisher","DOI":"10.1093\/scipol\/scs120"},{"key":"2026021511300996000_16.2.e104466.20","doi-asserted-by":"crossref","first-page":"111485","DOI":"10.1016\/j.jclinepi.2024.111485","article-title":"Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?","volume":"174","author":"Manyara","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"2026021511300996000_16.2.e104466.21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.17348\/era.5.0.147-158","article-title":"Purposive Sampling as a Tool for Informant Selection","volume":"5","author":"Tongco","year":"2007","journal-title":"Ethnobot Res App"},{"key":"2026021511300996000_16.2.e104466.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-020-01029-4","article-title":"Improving design choices in Delphi studies in medicine: the case of an exemplary physician multi-round panel study with 100% response","volume":"20","author":"Veugelers","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"2026021511300996000_16.2.e104466.23","first-page":"64","article-title":"Likert scales and data analyses","volume":"40","author":"Allen","year":"2007","journal-title":"Quality Progress"},{"key":"2026021511300996000_16.2.e104466.24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/info11090430","article-title":"Enhancing Software Comments Readability Using Flesch Reading Ease Score","volume":"11","author":"Eleyan","year":"2020","journal-title":"Information"},{"key":"2026021511300996000_16.2.e104466.25","doi-asserted-by":"crossref","first-page":"1609406915621381","DOI":"10.1177\/1609406915621381","article-title":"Utilizing and Adapting the Delphi Method for Use in Qualitative Research","volume":"14","author":"Brady","year":"2015","journal-title":"Int J Qual Methods"},{"key":"2026021511300996000_16.2.e104466.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.techfore.2012.04.013"},{"key":"2026021511300996000_16.2.e104466.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"key":"2026021511300996000_16.2.e104466.28","unstructured":"Ribeiro J . GDPR Impact on Research Procedures at FMUP: How to Improve GDPR Compliance of Research Procedures at the Faculty of Medicine of the University of Porto. 2023."},{"key":"2026021511300996000_16.2.e104466.29","doi-asserted-by":"crossref","unstructured":"Voigt P . The Eu General Data Protection Regulation (GDPR). A practical guide. 1st edn. Cham: Springer International Publishing, 2017:10\u20135555.","DOI":"10.1007\/978-3-319-57959-7"},{"key":"2026021511300996000_16.2.e104466.30","doi-asserted-by":"crossref","DOI":"10.1177\/2055207617740018","article-title":"Digital health now and in the future: Findings from a participatory design stakeholder workshop","volume":"3","author":"Lupton","year":"2017","journal-title":"Digit Health"},{"key":"2026021511300996000_16.2.e104466.31","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.050955"},{"key":"2026021511300996000_16.2.e104466.32","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000000673"},{"key":"2026021511300996000_16.2.e104466.33","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v11.i4.116"},{"key":"2026021511300996000_16.2.e104466.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201378","article-title":"Recruiting and retaining participants in e-Delphi surveys for core outcome set development: Evaluating the COMiT\u2019ID study","volume":"13","author":"Hall","year":"2018","journal-title":"PLoS One"},{"key":"2026021511300996000_16.2.e104466.35","first-page":"1","article-title":"Delphi method: strengths and weaknesses","volume":"16","author":"Fink-Hafner","year":"2019","journal-title":"Advanc Methodol Stat"},{"key":"2026021511300996000_16.2.e104466.36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.46661\/revmetodoscuanteconempresa.4010","article-title":"5-Item Likert Scale and Percentage Scale Correspondence with Implications for the Use of Models with (Fuzzy) Linguistic Variables","volume":"31","author":"Mazurek","year":"2021","journal-title":"RMCE"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-104466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T19:30:20Z","timestamp":1771183820000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-104466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,15]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-104466"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-104466","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}